Erectile Dysfunction Market Industry Forecast till 2024
Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/200
According to study conducted by Canadian Institute of Health Research, there were about 4,000 Canadian men between the age 40 and 88 years, nearly half of them had erectile dysfunction. It was about approximately two times more usual in men with cardiovascular disease and four times more usual among men suffering with any kind of diabetes. Increase in the number of erectile dysfunction cases has led to an increase in the Cialis drugs, proportionally boost the erectile dysfunction market.
The global erectile dysfunction market was valued at US$ 4,129.5 million in 2015 and is expected to witness a CAGR of 0.2% during the forecast period (2016 – 2024).
With the significant increase in revenue of Erectile Dysfunction Market, over last decade, more than 31 chemical moiety have advanced into the therapeutic pipeline, out of which 90% of drugs/molecules are developed by companies and 10% of the molecules/drugs are developed by Medical Universities and Institutes. However, the increase in the molecules and drug in clinical trials, the global drug pipeline for erectile dysfunction is still insufficient to address the unmet needs of treatment in low income countries. One of the basic challenge for the mid-level pharmaceutical companies are their lack of regional presence across the globe.
The global pharmaceutical companies are now involved in expansion of their erectile dysfunction product portfolio by merger and acquisition policies. For instance, in 2014, Endo Pharmaceutical Holdings Sale of American Medical Systems. In brief, some of the private equity firms are interested to buy American Medical Systems which is one of the leading manufacturer of products used to treat pelvic disorders of male and female, erectile dysfunction prostheses, and laser technology devices.
50 open clinical studies presently, to treat erectile dysfunction to boost the erectile dysfunction market
According to pharma industry news, in 2012, Viagra drugs dominated the erectile dysfunction market with an approximate market share of about 45% in terms of revenue. Though, the market value for Viagra has declined due to its patent expiry in European countries by 2013, however the other pharmaceutical companies has then shown a keen interest in developing the generic Viagra drug for erectile dysfunction treatment. In-spite the patent loss, US market maintained a continual growth and is expected to dominate the erectile dysfunction market by 2020.
Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/200
The other prominent drug after Viagra is Cialis which holds the second largest market share globally. At present the market for Cialis drug is growing exceptionally well, however there can be an expected decline of Cialis’s drug market share as the patent expiration is due in mid of 2017. Furthermore, one of the Bayer’s erectile dysfunction drug, Levitra/Staxyn is expected to lose its patent by 2018 and is thus expected to contribute to the declining market revenue for Erectile Dysfunction Market. However, as there about 50 drug molecules under clinical trials, among which few drugs are expected to launch by 2018 and 2019 owing to increase in Erectile Dysfunction Market proportionally.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erectile Dysfunction Market Industry Forecast till 2024 here
News-ID: 1185990 • Views: 403
More Releases from Coherent Market Insights
Spirometer Market Is Booming Worldwide 2021-2028 | Koninklijke Philips N.V., SCH …
Global Spirometer Market Difficulty in breathing is one of the most common problems affecting people across the world. Spirometer is a common device employed in the diagnosis and treatment of certain lung diseases. The device measures the inhalation and exhalation volumes of air in a single breath. Spirometers are usually employed for diagnosing Chronic Obstructive Pulmonary Disease (COPD) and asthma, as well as for monitoring other lung conditions, such as chronic
Biomarker Research Services Market to See Booming Growth 2021-2028 | Noble Life …
Biomarker Research Services Market to Surpass US$ 18.2 Billion Threshold by 2026 - Coherent Market Insights The global biomarker research services market is expected to witness significant growth over the forecast period. The market growth is attributed to factors such as increasing number of collaborations and partnerships, mergers and acquisitions, and product launches by key players. Furthermore, factors such as increasing application of biomarkers, and increasing usage of companion diagnostics for
Animal Genetics Market Overall Study Report 2021-2028 | Zoetis, Topigs Norsvin H …
Global Animal Genetics Market Animal genetics is a significant branch of biotechnology, which involves the study of genes, genetic variations, and heredity in animals. It studies gene expression, gene variants, reproduction, and traits in them. Animal genetics further includes genetic engineering, also known as recombinant DNA technology, which is a technique of manipulating the genes (adding or deleting of genes), which results in different combinations. It is used for genetic
Philippines Radiotherapy Market Detailed In New Research Report 2021 | Elekta AB …
Philippines Radiotherapy Market to Surpass US$ 27.7 Mn Threshold by 2026 - Coherent Market Insights Major market players are focusing on installing and increasing access of their technologically advanced radiotherapy products in the Philippines market. For instance, in 2015, Elekta installed new version Gamma Knife Perfexion stereotactic radiosurgery system at the Philippines Gamma Knife Center. Thus, installment of such novel devices in Philippines is expected to drive growth of the Philippines
More Releases for Erectile
Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobacco
50 Open Clinical Studies Presently, To Treat Erectile Dysfunction To Boost The E …
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratio
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, …
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Request for Sample of This Research Report @ https://bit.ly/2NXzatD Top Key Players:- Bayer AG Pfizer Eli Lilly & Co. Vivus, Inc. S.K. Chemicals Co. Ltd. Dong-A Pharmaceutical Co. Ltd Meda Pharmaceuticals Apricus Biosciences Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying According to a new study published by Polaris Market Research the global erectile dysfunction
Erectile Dysfunction: A Prominent Age Related Disorder
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a
Erectile Dysfunction - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Erectile Dysfunction - Pipeline Review, H2 2017”. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246564 The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants,
Erectile Dysfunction - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Erectile Dysfunction - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H1 2017, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have